Payload Information
General Information of This Payload
Payload ID | PAY0XPJRQ |
|||||
---|---|---|---|---|---|---|
Name | Mertansine DM1 plus IRDye700DX |
|||||
Synonyms |
Mertansine DM1 plus IRDye700DX
Click to Show/Hide
|
|||||
Target(s) | Microtubule (MT) |
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
T-DM1-IR700 [Investigative]
Discovered Using Cell Line-derived Xenograft Model
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 10.10% (Day 7) | Negative HER2 expression (HER2 -) | ||
Method Description |
Tra-IR700 (3.6 ug/g) or T-DM1-IR700 (3.6 ug/g) was administered intravenously to mice on Day 1 (without NIR light, 6 days after tumor cell transplantation). The dose similar to that of T-DM1 administered to humans (3.6 mg/kg). The NIR-light was irradiated at 1 and 2 days after the drug administration.
|
||||
In Vivo Model | MDA-MB-468GFP CDX model | ||||
In Vitro Model | Breast adenocarcinoma | MDA-MB-468GFP cells | CVCL_DH83 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Tumor Growth Inhibition value (TGI) | ≈ 36.40% (Day 7) | Negative HER2 expression (HER2 -) | ||
Method Description |
Tra-IR700 (3.6 ug/g) or T-DM1-IR700 (3.6 ug/g) was administered intravenously to mice on Day 1 (without NIR light, 6 days after tumor cell transplantation). The dose similar to that of T-DM1 administered to humans (3.6 mg/kg). The NIR-light was irradiated at 1 and 2 days after the drug administration.
|
||||
In Vivo Model | MDA-MB-468GFP CDX model | ||||
In Vitro Model | Breast adenocarcinoma | MDA-MB-468GFP cells | CVCL_DH83 |
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.10 nM - 10 nM
|
Positive HER2 expression (HER2+++/++) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Lung squamous cell carcinoma | NCI-H2170 cells | CVCL_1535 | ||
Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.10 nM - 10 nM
|
Positive HER2 expression (HER2+++/++) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Lung adenocarcinoma | Calu-3 cells | CVCL_0609 | ||
Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.10 nM - 10 nM
|
Low HER2 expression (HER2+) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Breast adenocarcinoma | MDA-MB-231 cells | CVCL_0062 | ||
Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
0.10 nM - 10 nM
|
Positive HER2 expression (HER2+++/++) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Lung adenocarcinoma | NCI-H1975 cells | CVCL_1511 | ||
Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
2.50 nM
|
Positive HER2 expression (HER2 +++/++) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Breast adenocarcinoma | 3T3/HER2-luc-GFP cells | Mus musculus | ||
Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
100 nM
|
Negative HER2 expression (HER2 -) | ||
Method Description |
Cells (100,000) were seeded in 12-well dishes and incubated with Tra-IR700 (10 ug/ml) or T-DM1-IR700 (10 ug/ml) for 6 h at 37°C. For NIR-PIT, cells were irradiated with 4 J/cm2 of NIR light from a 690 nm-Laser.
|
||||
In Vitro Model | Breast adenocarcinoma | MDA-MB-468GFP cells | CVCL_DH83 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.